Crystal commemorative marking the initial public offering of Australian biotech firm Chimeric Therapeutics. The firm is developing a class of cell therapy drugs for the treatment of cancer.
(21ALJ210)
Crystal commemorative marking the initial public offering of Australian biotech firm Chimeric Therapeutics. The firm is developing a class of cell therapy drugs for the treatment of cancer.
(21ALJ210)
Back view of custom crystal celebrating the initial public offering on the Australia Securities Exchange of Chimeric Therapeutics. (21ALJ210)